Investigational Site Number 804011

Kyiv 03680

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia, Rheumatoid Arthritis

Studies at this site

• Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate — Stopped early
• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed